BioNexus Gene Lab (BGLC) regains full Nasdaq compliance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. NVDA
3. SBUX
4. SPY
5. GOOGL
6. APLD
7. USO
8. STZ
9. AGNT
10. ORCL

Go back to BioNexus Gene Lab (BGLC) regains full Nasdaq compliance

BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness

April 30, 2025 11:25 AM EDT

KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC), a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today announced that it has received official notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming the Company has regained full compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share.

This important milestone reaffirms the Companys standing as a compliant and growth-focused public company. It marks the successful conclusion of a focused compliance initiative and paves the way for the... More